People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart ...

Retatrutide, an experimental injectable drug, targets three hormones related to weight loss.

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 ...

While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three ...

MEDVi offers GLP-1 weight loss drugs online, but is it worth it? Review pricing, pros, cons, and what customers have to say.

A study in mice showed how T2D drug metformin exerts multiple clinical effects through selective inhibition of mitochondrial ...

Retatrutide helped people lose 70 pounds on average, or 28% of their body weight, in a clinical trial. The Eli Lilly weight-loss drug mimics three gut hormones.

A next-gen Eli Lilly obesity drug led to bariatric-surgery levels of weight loss in a study, but also saw patients dropping ...

Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...

In a clinical trial, the new weight-loss medication retatrutide led to "clinically meaningful weight reduction," with the ...

Long before GLP-1 medications like Ozempic and Mounjaro became both ubiquitous in TV advertisements and the preferred options for treating Type 2 diabetes, doctors often prescribed metformin — a drug ...